INH preventive therapy among adult HIV-infected patients in Thailand

International Journal of Tuberculosis and Lung Disease

Volumn 9, Issue 3, 2005, Pages 270-275

  Hiransuthikul, N ^a   Nelson, K E ^b   Hiransuthikul, P ^a   Vorayingyong, A ^a   Paewplot, R ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Adherence; Human immunodeficiency virus; Isoniazid; Preventive therapy; Thailand; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID; TUBERCULIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPING COUNTRY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCREENING; SELF REPORT; THAILAND; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

ADULT; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HIV; HIV INFECTIONS; HUMANS; ISONIAZID; MALE; PATIENT COMPLIANCE; PATIENT DROPOUTS; PREVALENCE; THAILAND; TREATMENT OUTCOME; TUBERCULIN TEST; TUBERCULOSIS;

EID: 15344340918     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Gordin F M, Matts J P, Miller C, et al. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS. N Engl J Med 1997; 337: 315-320.
2. Gordin F, Chaisson R E, Matts J P, et al. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group. JAMA 2000; 283: 1445-1450.
3. Pape J W, Jean S S, Ho J L, Hafner A, Johnson W D Jr. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993; 342: 268-272.
4. Whalen C C, Johnson J L, Okwera A, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. N Engl J Med 1997; 337: 801-808.
5. Graham N M, Galai N, Nelson K E, et al. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Arch Intern Med 1996; 156: 889-894.
6. World Health Organization. Preventive therapy against tuberculosis in people living with HIV. Wkly Epidemiol Rec 1999; 74: 385-398.
7. Hawken M P, Muhindi D W. Tuberculosis preventive therapy in HIV-infected persons: feasibility issues in developing countries. Int J Tuberc Lung Dis 1999; 3: 646-50.
8. De Cock K M, Grant A, Porter J D. Preventive therapy for tuberculosis in HIV-infected persons: international recommendations, research, and practice. Lancet 1995; 345: 833-836.
9. Caiaffa W, Graham N M H, Astemborski J et al. Instability of delayed-type hypersensitivity (DTH) skin test anergy in human immunodeficiency virus (HIV) infection. Arch Intern Med 1995; 155: 2111-2117.
10. Aisu T, Raviglione M C, van Praag E, et al. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre. AIDS 1995; 9: 267-273.
11. Sackoff J E, Torian L V, Frieden T R, Brudney K F, Menzies I B. Purified protein derivative testing and tuberculosis preventive therapy for HIV-infected patients in New York City. AIDS 1998; 12: 2017-2023.
12. Ngamvithayapong J, Uthaivoravit W, Yanai H, Akarasewi P, Sawanpanyalert P. Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, Thailand. AIDS 1997; 11: 107-112.
13. Huebner R E, Schein M F, Hall C A, Barnes S A. Delayed-type hypersensitivity anergy in human immunodeficiency virus-infected persons screened for infection with Mycobacterium tuberculosis. Clin Infect Dis 1994; 19: 26-32.
14. Hiransuthikul N, Hanvanich M, Dore G, et al. Factors associated with tuberculin skin test reactivity among HIV-infected people in Bangkok. Southeast Asian J Trop Med Public Health 2003; 34: 804-809.
15. Chuah S Y. Factors associated with poor patient compliance with antituberculosis therapy in Northwest Perak, Malaysia. Tubercle 1991; 72: 261-264.